| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/16/2009 | WO2009047756A2 Methods and kits for diagnosing lung cancer |
| 04/16/2009 | WO2009047687A2 Microfluidic device comprising a multitude of micropillars |
| 04/16/2009 | WO2009047655A2 Phase change visual indicating composition |
| 04/16/2009 | WO2009047532A2 Cancer susceptibility loci |
| 04/16/2009 | WO2009047529A1 Method of detecting the risk of cancer using genetic markers |
| 04/16/2009 | WO2009047523A1 Protease inhibition |
| 04/16/2009 | WO2009047517A1 Ptgs2 haplotypes |
| 04/16/2009 | WO2009047515A1 Method of identifying cancer risk markers |
| 04/16/2009 | WO2009047489A1 Methods for measuring depolymerase activity |
| 04/16/2009 | WO2009047363A1 Pharmaceuticals compositions comprising actinomycete glycerol acyl derivatives antigens, their process of extraction, and their use against tuberculosis |
| 04/16/2009 | WO2009047327A1 Measurement of arylesterase enzymatic activity and assessment of genetic polymorphisms located in the pon1 gene as a diagnostic tool in autism-spectrum disorders |
| 04/16/2009 | WO2009047274A2 Ptpl1 as a biomaker of survival in breast cancer |
| 04/16/2009 | WO2009047062A2 Molecular markers for cancer prognosis |
| 04/16/2009 | WO2009047001A1 Non-thiopurine methyltransferase related effects in 6-mercaptopurine therapy |
| 04/16/2009 | WO2009046983A1 Soluble fragments of influenza virus pb2 protein capable of binding rna-cap |
| 04/16/2009 | WO2009046972A2 Microarray for expression analysis of cellular glycosylation mechanism |
| 04/16/2009 | WO2009046917A2 Marker for the diagnosis of cancer |
| 04/16/2009 | WO2009046724A2 Polymorphisms of mbl |
| 04/16/2009 | WO2009046557A1 Enzymatic methods and enzymes |
| 04/16/2009 | WO2009046541A1 MODULATION OF SIRPα - CD47 INTERACTION FOR INCREASING HUMAN HEMATOPOIETIC STEM CELL ENGRAFTMENT AND COMPOUNDS THEREFOR |
| 04/16/2009 | WO2009046535A1 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 04/16/2009 | WO2009046514A1 Methods for non-invasive collection of skin cells for dna analysis |
| 04/16/2009 | WO2009028945A3 Pathways involved in arteriogenesis and uses thereof |
| 04/16/2009 | WO2009023547A3 Polymer microfluidic biochip fabrication |
| 04/16/2009 | WO2009023495A3 Bisubstrate inhibitors of adenylosuccinate synthetase |
| 04/16/2009 | WO2009023056A3 Systems and methods for detecting toxins in a sample |
| 04/16/2009 | WO2009023048A9 Markers for metabolic syndrome |
| 04/16/2009 | WO2009021684A3 Predictive marker for egfr inhibitor treatment |
| 04/16/2009 | WO2009021054A3 Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene |
| 04/16/2009 | WO2009020601A3 Atf4 inhibitors and their use for neural protection, repair, regeneration, and plasticity |
| 04/16/2009 | WO2009020346A3 A gastric carcinoma gene znf312b, a protein translated from the gene, and a diagnostic kit and a screening method for anticancer agents using the same |
| 04/16/2009 | WO2009017678A3 Molecular redundant sequencing |
| 04/16/2009 | WO2009012468A3 Differential expression of micrornas in nonfailing versus failing human hearts |
| 04/16/2009 | WO2009012309A3 Nucleic acid based fluorescent sensor for divalent copper ion detection |
| 04/16/2009 | WO2009012110A3 Unique calibrator polynucleotides and methods of using in quantitative nucleic acid assays |
| 04/16/2009 | WO2009005688A3 Activating mutations in notch-1 |
| 04/16/2009 | WO2009005542A3 Detection of bioagents using a shear horizontal surface acoustic wave biosensor |
| 04/16/2009 | WO2009001051A3 Fluorescence lifetime and fluorescence assays |
| 04/16/2009 | WO2008147345A3 System and method for antigen structure-independent detection of antigens captured on antibody arrays |
| 04/16/2009 | WO2008137549A3 Methods and compositions for diagnosing osteoarthritis in a feline |
| 04/16/2009 | WO2008130981A3 Methods and compositions for selecting soybean plants resistant to phytophthora root rot |
| 04/16/2009 | WO2008130949A3 Modulating nurr1 expression in a cell |
| 04/16/2009 | WO2008125247A3 Novel medical diagnostic method and therapy in the context of interferon-stimulated genes that induce depression |
| 04/16/2009 | WO2008114145A8 Methods of producing haploid and doubled haploid oil palms |
| 04/16/2009 | WO2008076156A3 Glms riboswitches, structure-based compound design with glms riboswitches, and methods and compositions for use of and with glms riboswitches |
| 04/16/2009 | WO2008070672A3 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 04/16/2009 | WO2008070198A3 Thermal cycling system |
| 04/16/2009 | WO2008058752A3 Lentiviral vectors for gene transfer in quiescent (g0) cells |
| 04/16/2009 | WO2008055916A9 New antigens for paratuberculosis diagnosis and vaccination |
| 04/16/2009 | WO2008054600A3 Compositions and methods for biodetection by nucleic acid-templated chemistry |
| 04/16/2009 | WO2008033164A8 Magnetic particle tagged reagents and techniques |
| 04/16/2009 | WO2008028002A9 Increasing nadph-dependent products |
| 04/16/2009 | WO2008024835A3 Microfluidic devices and methods facilitating high-throughput, on-chip detection and separation techniques |
| 04/16/2009 | WO2008022045A3 Differential labeling of cells |
| 04/16/2009 | WO2008019159A3 Controlling osteogenesis by inhibition of osteogenic suppressors |
| 04/16/2009 | WO2007133189A3 Methods and agents for detecting parechovirus |
| 04/16/2009 | WO2007111628A3 Mxa as an antiviral drug and as a target for identification of antiviral drugs for dna virus infections |
| 04/16/2009 | WO2007110869A3 Methods and kits for determining predisposition to warfarin resistance |
| 04/16/2009 | WO2007080442A3 Method to determine state of a cell exchanging metabolites with a fluid medium by analyzing the metabolites in the fluid medium |
| 04/16/2009 | WO2007063543A3 System for counting bacteria and determining their susceptibility to antibiotics |
| 04/16/2009 | WO2007040654A3 Methods to identify antimicrobial compounds that interrupt ribosome biogenesis |
| 04/16/2009 | WO2007033283A3 Disposable electrode system for detection of selected nucleic acid sequences |
| 04/16/2009 | WO2007022419A3 Molecular toxicity models from isolated hepatocytes |
| 04/16/2009 | WO2007019064A3 ANTI-TNFα ANTIBODIES AND METHODS OF USE |
| 04/16/2009 | WO2007018853A3 Secretion of antibodies without signal peptides from bacteria |
| 04/16/2009 | WO2007018734A3 Q-melt for polymorphism detection |
| 04/16/2009 | WO2007008583A3 Improved protein expression comparison assay results and applications |
| 04/16/2009 | WO2007005559A3 Tat-005 and methods of assessing and treating cancer |
| 04/16/2009 | WO2007002718A3 Rnai modulation of hif-1 and theraputic uses thereof |
| 04/16/2009 | WO2007002087A3 Cdc6s as modifiers of the pten/akt pathway and methods of use |
| 04/16/2009 | WO2007001986A3 Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations |
| 04/16/2009 | WO2006133295A3 SUSCEPTIBILITY GENES FOR AGE-RELATED MACULOPATHY (ARM) ON CHROMOSOME 10q26 |
| 04/16/2009 | WO2006130872A3 Peptide nucleic acid probes for analysis of microorganisms |
| 04/16/2009 | WO2006130477A3 Methods and compositions for determining resistance of hiv-1 to protease inhibitors |
| 04/16/2009 | WO2006128117A3 Polymorphisms in mitochondrial transcription factor a (tfam) gene and their associations with measures of marbling and subcutaneous fat dept in beef cattle |
| 04/16/2009 | WO2006128041A3 Compositions and methods for the treatment or prevention of chemoresistant neoplasia |
| 04/16/2009 | WO2006127537A3 Thyroid fine needle aspiration molecular assay |
| 04/16/2009 | WO2006124664A3 Polymorphic ghsr nucleic acids and uses thereof |
| 04/16/2009 | WO2006122295A3 Methods of monitoring functional status of transplants using gene panels |
| 04/16/2009 | WO2006121951A3 Antisense antiviral compounds and methods for treating foot and mouth disease |
| 04/16/2009 | WO2006121866A3 Sequence enabled reassembly (seer) - a novel method for visualizing specific dna sequences |
| 04/16/2009 | WO2006121710A3 Bladder cancer biomarkers and uses thereof |
| 04/16/2009 | WO2006118566A3 Assessing brain aneurysms |
| 04/16/2009 | WO2006116684A3 Methods of predicting methotrexate efficacy and toxicity |
| 04/16/2009 | WO2006116602A3 Markers associated with the therapeutic efficacy of glatiramer acetate |
| 04/16/2009 | WO2006116400A3 Promoter engineering and genetic control |
| 04/16/2009 | WO2006116174A3 Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase |
| 04/16/2009 | WO2006113790A3 Compositions and methods for the treatment of cancer |
| 04/16/2009 | WO2006112939A3 Compositions, methods, and kits for analyzing dna methylation |
| 04/16/2009 | WO2006112842A3 Microarray gene expression profiling in classes of papillary renal cell carcinoma |
| 04/16/2009 | WO2006108101A3 Devices and method for enrichment and alteration of cells and other particles |
| 04/16/2009 | WO2006104778A3 Compositions and methods for detecting protease activity |
| 04/16/2009 | WO2006102542A3 Diverse chemical libraries bound to small particles with paramagnetic properties |
| 04/16/2009 | WO2006102498A3 Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy |
| 04/16/2009 | WO2006102129A3 Metal mediated fluorescence superquenching assays for detection of phosphorylation and dephosphorylation of quencher-labeled substrates |
| 04/16/2009 | WO2006101623A3 Cstf1 and c20orf43 markers for meat quality and growth rate in animals |
| 04/16/2009 | WO2006098752A3 Ultrasensitive sensor and rapid detection of analytes |
| 04/16/2009 | WO2006094068A3 Hdac inhibitors that promote brm expression and brm related diagnostics |
| 04/16/2009 | WO2006091979A3 Full karyotype single cell chromosome analysis |
| 04/16/2009 | WO2006091579A3 Identification of a gene associated with spinocerebellar ataxia type 5 and methods of use |